<In NEW YORK story headlined "Scios 2nd-qtr loss widens as
costs offset drug sales," please read in last paragraph ...59
cents... instead of ...49 cents ... (Corrects Thomson First
Call estimate).
A corrected version follows.
NEW YORK, July 25 (Reuters) - Scios Inc. (SCIO - news) said on
Thursday its second-quarter loss widened as increased research
and marketing costs offset higher sales of its heart drug.
Scios, based in Sunnyvale, California, said its net loss
widened to $22.5 million, or 48 cents a share, from $18.3
million, or 46 cents, a year ago.
Revenue rose to $23 million from $5.2 million, lifted by
higher sales of Natrecor, the company's treatment for acute
heart failure.
Analysts had on average expected the company to post a loss
of 59 cents a share, according to Thomson First Call. >
quid |
